Delaware
|
0-12957
|
22-2372868
|
||
(State
or Other Jurisdiction of
Incorporation)
|
(Commission
File
Number)
|
(IRS
Employer
Identification
No.)
|
685
Route 202/206, Bridgewater, NJ
|
08807
|
|
(Address
of Principal Executive Offices)
|
(Zip
Code)
|
Not
Applicable
|
(Former
Name or Former Address, if Changed Since Last
Report)
|
o |
Written
communications pursuant to Rule 425 under the Securities Act (17 CFR
230.425)
|
o |
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
|
o |
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR
240.14d-2(b))
|
o |
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR
240.13e-4(c))
|
Item
5.02.
|
Departure
of Directors or Certain Officers; Election of Directors; Appointment of
Certain Officers; Compensatory Arrangements of Certain
Officers.
|
Item
9.01.
|
Financial
Statements and Exhibits.
|
Exhibit
No.
|
Exhibit
|
|
99.1
|
Enzon
Pharmaceuticals, Inc. press release, dated February 22,
2010.
|
ENZON
PHARMACEUTICALS, INC.
|
||
By:
|
/s/
Craig A. Tooman
|
|
Name:
|
Craig
A. Tooman
|
|
Title:
|
Executive
Vice President, Finance and Chief Financial
Officer
|
Exhibit
No.
|
Exhibit
|
|
99.1
|
Enzon
Pharmaceuticals, Inc. press release, dated February 22,
2010.
|